Warning: count(): Parameter must be an array or an object that implements Countable in /home/logicben/public_html/drugtrialsformoney.com/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 391

First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours

Conditions: Clear Cell Renal Cell Cancer; Non-Small-Cell Lung Cancer; Triple Negative Breast Neoplasms; Squamous Cell Cancer of Head and Neck; Small Cell Lung Cancer; Gastric Cancer; Melanoma; Cervical Cancer; Advanced Solid Tumours
Interventions: Drug: AZD8701; Biological: Durvalumab
Sponsor: AstraZeneca
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 23, 2020 / by ClinicalTrials.gov / in Gastroenterology

Comments